Stock T14 TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Singapore S.E.

Equities

T14

CNE100000924

Delayed Singapore S.E.
Other stock markets
 11:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
2.01 USD +2.03% Intraday chart for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited +1.01% -2.90%
Apr. 02 Tianjin Pharmaceutical Da Ren Tang's 2023 Profit Rises 14.5% MT
Mar. 29 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

  1. Stock Market
  2. Equities
  3. 600329 Stock
  4. T14 Stock
  5. Revisions Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited